AI and ML Get FDA Boost for Drug Trials and Development

The FDA acknowledges that AI/ML is being used more and more in medication development.

 In 2021, more than 100 AI/ML contributions were recorded.

Postmarket safety surveillance, clinical research, and drug development are all being transformed by AI/ML.

The FDA is dedicated to supporting innovation while maintaining the safety of pharmaceuticals.

A discussion paper investigating AI/ML in drug development was released.